Published Date:2021-09-04 Original Link:https://www.onenessbio.com/en/news_detail56_2.htm No 2 Date of announcement 2021/09/04 Time of announcement 12:23:26 Subject The data of the Phase 3 international multicenter clinical trial and the mechanism of action of Fespixon (ON101) have been published by JAMA Network Open      To which item it meets paragraph 53 Date of events 2021/09/03 Statement   ...Read More

Published Date:2021-09-04 Original Link:https://www.onenessbio.com/en/news_detail55_2.htm No 1 Date of announcement 2021/09/04 Time of announcement 00:51:50 Subject Oneness decided not to proceed with FB704A phase 2 IND application in patients with severe COVID-19 based on strategic consideration      To which item it meets paragraph 10 Date of events 2021/09/03 Statement 1.Product:FB704A 2.Mass production date:NA 3.Effect on...Read More